Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.880
+0.050 (2.73%)
At close: Mar 6, 2026, 4:00 PM EST
1.850
-0.030 (-1.60%)
After-hours: Mar 6, 2026, 4:56 PM EST
CMMB's stock price has decreased by -66.43% in the past year and price targets may not have had time to catch up.

Chemomab Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Buy
Price Target
$25.00
Upside
+1,229.79%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
Buy Maintains $10$25 +1,229.79% Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
Buy Maintains $44$40 +2,027.66% May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong Buy Maintains $16$28 +1,389.36% Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
Buy Reiterates $52$44 +2,240.43% Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong Buy Initiates $16 +751.06% May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
Buy Upgrades $24 +1,176.60% May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,389.36% Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,389.36% Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
Buy Maintains $48$28 +1,389.36% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
Buy Maintains $120$80 +4,155.32% Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong Buy Initiates $120 +6,282.98% Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
Buy Initiates $180 +9,474.47% May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
Buy Initiates $168 +8,836.17% May 7, 2021